Although several studies have demonstrated the intracellular effects of oncogenic mutant p53 in tumor growth, invasion, and metastasis as well as anoikis resistance [34–37], the crosstalk between mutant p53-driven tumor development and TME has gained increasing interest. Here, TP53 is linked to neoplasm.